TP53 and breast cancer: Here, we demonstrated that the pharmalogical reactivation of a wt-like p53 transcriptional function in p53-mutated breast cancer cells using the small molecule CP-31398 increases their susceptibility to NK cell-mediated lysis by an autophagy-dependent mechanism.